Drug name |
Drug type |
Disease/phenotype |
Mechanism of action(MoA) |
Phase |
Status |
Source |
ROSIPTOR | Small molecule | interstitial cystitis | Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activator | 2.0 | Completed | ClinicalTrials |
ROSIPTOR | Small molecule | atopic eczema | Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activator | 2.0 | Completed | ClinicalTrials |
ROSIPTOR | Small molecule | interstitial cystitis | Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activator | 3.0 | Unknown status | ClinicalTrials |
ROSIPTOR | Small molecule | chronic interstitial cystitis | Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activator | 3.0 | Unknown status | ClinicalTrials |
ROSIPTOR | Small molecule | chronic obstructive pulmonary disease | Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activator | 2.0 | Completed | ClinicalTrials |